Clinical Trial to Assess the Efficacy and Toxicity of Induction and Consolidation With CPX-351 for Patients Aged 60 to 75 Years With Secondary or High-risk Acute Myeloid Leukemia

Clinical trial NCT04230239 · COMPLETED

Trial details

NCT number: NCT04230239
Sponsor: PETHEMA Foundation
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Newly Diagnosed Secondary or High Risk AML

Start date: 2019-12-26
Primary completion: 2021-04-30
Enrollment: 59

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.